BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han RC, Fry LE, Kantor A, McClements ME, Xue K, MacLaren RE. Is subretinal AAV gene replacement still the only viable treatment option for choroideremia? Expert Opin Orphan Drugs 2021;9:13-24. [PMID: 34040899 DOI: 10.1080/21678707.2021.1882300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Kalatzis V, Roux AF, Meunier I. Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date. Mol Diagn Ther 2021. [PMID: 34661884 DOI: 10.1007/s40291-021-00558-y] [Reference Citation Analysis]